Nayak, S U <br/><br/>
Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Sep 2014 
 - 5047-53 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.02830-14  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Antibodies, Monoclonal--adverse effects<br/>Area Under Curve<br/>Botulinum Toxins, Type A--antagonists & inhibitors<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Mice<br/>Young Adult